×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MGRX – mangoceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MGRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/17
04:43 pm
mgrx
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. [Yahoo! Finance]
Medium
Report
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. [Yahoo! Finance]
3/17
04:00 pm
mgrx
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
Medium
Report
Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
3/6
04:44 pm
mgrx
Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds [Yahoo! Finance]
High
Report
Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds [Yahoo! Finance]
3/6
04:00 pm
mgrx
Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
Medium
Report
Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
2/23
04:37 pm
mgrx
Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study [Yahoo! Finance]
Low
Report
Mangoceuticals' Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study [Yahoo! Finance]
2/23
04:05 pm
mgrx
Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
Medium
Report
Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study
2/19
04:05 pm
mgrx
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
High
Report
MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/20
05:01 pm
mgrx
Form 4 MANGOCEUTICALS, INC. For: Jun 05 Filed by: Cohen Jacob D.
Low
Report
Form 4 MANGOCEUTICALS, INC. For: Jun 05 Filed by: Cohen Jacob D.
3/20
05:01 pm
mgrx
Form 4 MANGOCEUTICALS, INC. For: Mar 16 Filed by: Cohen Jacob D.
Low
Report
Form 4 MANGOCEUTICALS, INC. For: Mar 16 Filed by: Cohen Jacob D.
3/17
04:00 pm
mgrx
Form 8-K MANGOCEUTICALS, INC. For: Mar 16
High
Report
Form 8-K MANGOCEUTICALS, INC. For: Mar 16
2/23
04:06 pm
mgrx
Form 8-K MANGOCEUTICALS, INC. For: Feb 23
Low
Report
Form 8-K MANGOCEUTICALS, INC. For: Feb 23
2/19
04:06 pm
mgrx
Form 8-K MANGOCEUTICALS, INC. For: Feb 19
High
Report
Form 8-K MANGOCEUTICALS, INC. For: Feb 19
2/6
04:31 pm
mgrx
Form 8-K MANGOCEUTICALS, INC. For: Feb 04
Low
Report
Form 8-K MANGOCEUTICALS, INC. For: Feb 04
1/29
06:06 am
mgrx
Form EFFECT MANGOCEUTICALS, INC.
High
Report
Form EFFECT MANGOCEUTICALS, INC.
1/23
05:07 pm
mgrx
Form S-1/A MANGOCEUTICALS, INC.
High
Report
Form S-1/A MANGOCEUTICALS, INC.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: